Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (231-240 of 361) with videos related to

Pageof 37
Sort By:
Bone Marrow Transplantation|June 19, 2025
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AMLGuillaume Dachy, Myriam Labopin, Gérard Socié, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2023
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)Marissa Wilck, Oliver A Cornely, Catherine Cordonnier, et al.
The New England Journal of Medicine|March 18, 2011
Cytarabine dose for acute myeloid leukemiaBob Löwenberg, Thomas Pabst, Edo Vellenga, et al.
Blood Advances|January 4, 2018
Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1Jurjen Versluis, Myriam Labopin, Annalisa Ruggeri, et al.
Blood|January 11, 2007
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?Jan J Cornelissen, Wim L J van Putten, Leo F Verdonck, et al.
Bone Marrow Transplantation|August 20, 2024
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMTArnon Nagler, Myriam Labopin, Urpu Salmenniemi, et al.
Leukemia|April 29, 2022
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)Simone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
BMC Cancer|April 27, 2025
Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
The Journal of Antimicrobial Chemotherapy|February 15, 2008
Risk factors for breakthrough invasive fungal infection during secondary prophylaxisOliver A Cornely, Angelika Böhme, Dietmar Reichert, et al.
Journal of Clinical Microbiology|March 24, 2022
Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a <i>Post Hoc</i> Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis StudyDaniele Roberto Giacobbe, Juergen Prattes, Joost Wauters, et al.
Pageof 37

Showing results (231-240 of 361) with videos related to

Sort By:
Pageof 37
Bone Marrow Transplantation|June 19, 2025
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AMLGuillaume Dachy, Myriam Labopin, Gérard Socié, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2023
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)Marissa Wilck, Oliver A Cornely, Catherine Cordonnier, et al.
The New England Journal of Medicine|March 18, 2011
Cytarabine dose for acute myeloid leukemiaBob Löwenberg, Thomas Pabst, Edo Vellenga, et al.
Blood Advances|January 4, 2018
Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1Jurjen Versluis, Myriam Labopin, Annalisa Ruggeri, et al.
Blood|January 11, 2007
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?Jan J Cornelissen, Wim L J van Putten, Leo F Verdonck, et al.
Bone Marrow Transplantation|August 20, 2024
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMTArnon Nagler, Myriam Labopin, Urpu Salmenniemi, et al.
Leukemia|April 29, 2022
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)Simone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
BMC Cancer|April 27, 2025
Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
The Journal of Antimicrobial Chemotherapy|February 15, 2008
Risk factors for breakthrough invasive fungal infection during secondary prophylaxisOliver A Cornely, Angelika Böhme, Dietmar Reichert, et al.
Journal of Clinical Microbiology|March 24, 2022
Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a <i>Post Hoc</i> Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis StudyDaniele Roberto Giacobbe, Juergen Prattes, Joost Wauters, et al.
Pageof 37